Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.32 |
| ▸ | PRKCI | P41743 | 1/20 | 0.31 |
| ▸ | GNG2 | P59768 | 1/20 | 0.30 |
| ▸ | GNB1 | P62873 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27554810 | 0.98 | GSK3B (0.38) | GSK3BALDH1A1MAPTL3MBTL1NPC1 | |
| SCHEMBL6169100 | 0.81 | PDE3B (0.40) | GSK3BALDH1A1MAPTL3MBTL1NPC1 | |
| SCHEMBL6170563 | 0.79 | KDM4E (0.39) | GSK3BMAPTPTPN1PRKCIGNG2 | |
| SCHEMBL6110659 | 0.75 | KDM4E (0.46) | GSK3BALDH1A1MAPTL3MBTL1PTPN1 | |
| Bromide SCHEMBL5634492 | 0.73 | GSK3B (0.33) | GSK3BALDH1A1NPC1RAB9AKMT2A | |
| Bromide SCHEMBL6111604 | 0.71 | CTNNB1 (0.47) | GSK3BALDH1A1MAPTL3MBTL1NPC1 | |
| Bromide SCHEMBL6168819 | 0.71 | GSK3B (0.40) | GSK3BALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL4973075 | 0.70 | GSK3B (0.34) | GSK3BALDH1A1NPC1RAB9AKMT2A | |
| SCHEMBL13180249 | 0.70 | GABRA1 (0.37) | ALDH1A1MAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL6170342 | 0.69 | GSK3B (0.41) | GSK3BALDH1A1MAPTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1045833-B1 | 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS | PFIZER (US) | 2005-11-02 | — | — | EP | disclosed |
| US-6608070-B1 | Useful for treatment of medical condition in which prostaglandins are implicated as pathogens | NAKAO KAZUNARI (JP) | 2003-08-19 | — | — | US | disclosed |
| EP-1045833-A1 | 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS | PFIZER INC. (US) | 2000-10-25 | — | — | EP | disclosed |
| WO-1999035130-A1 | 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS | PFIZER PHARMACEUTICALS INC. (JP) | 1999-07-15 | — | — | WO | disclosed |